|
?:authorAffiliation
|
-
[\'Vaxine Pty Ltd., Bedford Park, Adelaide 5042, SA, Australia; College of Medicine and Public Health, Flinders University, Adelaide 5042, SA, Australia.\', \'Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA.\', \'Vaxine Pty Ltd., Bedford Park, Adelaide 5042, SA, Australia.\', \'Department of Pathology, University of Georgia, Athens, GA, USA.\', \'Centre for Virus Research, Westmead Millennium Institute, Westmead Hospital and University of Sydney, Sydney 2145, NSW, Australia.\', \'College of Medicine and Public Health, Flinders University, Adelaide 5042, SA, Australia.\', \'School of Medical Sciences and Marie Bashir Institute, University of Sydney, Sydney, NSW 2006, Australia.\', \'Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.\', \'Vaxine Pty Ltd., Bedford Park, Adelaide 5042, SA, Australia; College of Medicine and Public Health, Flinders University, Adelaide 5042, SA, Australia. Electronic address: nikolai.petrovsky@flinders.edu.au.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}